Worldwide
Worldwide / Long-Haul
Long-haul worldwide travel presents maximum DVT risk, complex time zone medication management, and extended periods away from your New Zealand oncology team.
Popular for once-in-a-lifetime travel, extended overseas stays, multi-destination world trips, and visiting family in Europe or the Americas.
Key Considerations
- !DVT risk on flights exceeding 6 hours is significantly elevated for cancer patients — cancer itself increases clotting risk 4–7 times, compounded by long-haul flight immobility
- !Crossing multiple time zones requires a clear plan for maintaining medication schedules — particularly for daily oral medications like levothyroxine, tamoxifen, or targeted therapies
- !Extended periods away from your NZ oncology team require careful planning: PSA tests, CA-125 monitoring, blood counts, or other surveillance may need to be arranged overseas
- !A worldwide policy must be in place before departure — it typically cannot be purchased after you've left New Zealand
Insurance Tip
For long-haul worldwide travel, a worldwide policy (not a regional or country-specific policy) is required. Ensure the policy includes unlimited medical cover and medical evacuation back to New Zealand — the cost of getting you home from Europe, the Americas, or Africa in a medical emergency is substantial. Discuss DVT prevention with your oncologist before any flight exceeding 4 hours.
Full Guide
Worldwide Long-Haul Travel with Cancer: Managing DVT, Medications, and Maximum Distance from Home
Long-haul worldwide travel — whether a multi-week Europe trip, a journey to South America, a circumnavigation, or an extended stay overseas — represents the highest-stakes travel scenario for cancer patients. The distances are greater, the flight durations are longer, the time zones are more disorienting, the periods away from your oncology team are extended, and the cost of getting you home in a medical emergency is at its maximum. None of this makes worldwide travel impossible or even inadvisable for the right patient at the right time — but it demands the most careful preparation, the most comprehensive insurance, and the clearest communication with your oncologist.
Medical Facilities and Healthcare Access
Worldwide travel, by definition, encompasses a wide range of medical environments. Major cities across the Americas, Europe, Africa, and Asia all have capable hospitals — but quality varies as much as it does in any single region. The critical principle for worldwide travel is to understand the medical landscape of every portion of your journey, not just the headline destination.
A world trip that spends a week in London (excellent), a week in Egypt's Cairo (good in private sector, limited in public), four days on safari in Kenya (very limited outside Nairobi), and a week in South Africa (Cape Town and Johannesburg: good private sector; rural: limited) presents a layered medical risk profile. Knowing that before you go — and having insurance that covers evacuation from each of those environments — is the foundation of safe worldwide travel.
No Reciprocal Healthcare Anywhere (Except Australia)
Australia is the only destination with a reciprocal healthcare arrangement relevant to travellers from this country, and as noted in the Australia guide, that agreement has significant limitations for cancer patients. Everywhere else in the world — every country, every continent — you are an uninsured visitor without travel insurance. A worldwide policy is not optional; it is the entire financial safety net.
Key Risks for Cancer Patients
DVT on Long-Haul and Ultra-Long-Haul Flights
This is the most important medical risk for cancer patients on long-haul travel, and it deserves detailed attention.
Deep vein thrombosis occurs when blood clots form in the deep veins of the leg, typically the calf or thigh, during periods of prolonged immobility. Cancer increases clotting risk substantially — research consistently suggests cancer patients have a 4 to 7 times higher baseline clotting risk than the general population. The mechanisms include cancer-related release of procoagulant factors, treatment effects (some chemotherapy agents increase clotting risk; certain hormonal therapies like tamoxifen significantly increase DVT risk), and reduced mobility from cancer-related fatigue.
On a 12-hour flight to Los Angeles, a 24-hour journey to London, or an ultra-long-haul to South America or Africa, the compounded risk of cancer, immobility, and altitude is material. A DVT that propagates to a pulmonary embolism is a life-threatening emergency — and the irony is that it can occur days after the flight, once you are already at your destination.
Before booking any flight exceeding 4 hours, discuss the following with your oncologist:
- What is your current thrombotic risk based on your cancer type and stage?
- Are you on any medications that increase clotting risk (certain chemotherapy agents, hormonal therapies)?
- Are compression stockings sufficient, or do you need pharmacological prophylaxis (low-molecular-weight heparin injection before long flights)?
- If you are on anticoagulants already, is your current regimen adequate for long-haul travel?
In-flight: move around the cabin every 1 to 2 hours, do ankle circles and leg movements in your seat, stay hydrated, avoid alcohol, wear graduated compression stockings (not flight socks — properly measured compression stockings). Book an aisle seat.
Medication Management Across Multiple Time Zones
A multi-week worldwide trip may cross 8, 10, or even 12 time zones. For cancer patients taking daily oral medications — particularly those with narrow therapeutic windows — this requires a detailed, written medication timing plan developed with your oncologist or pharmacist before departure.
Medications particularly affected by time zone changes include:
- Levothyroxine (thyroid cancer or hypothyroidism post-thyroidectomy) — timing relative to food matters; gradual adjustment is possible
- Tamoxifen and aromatase inhibitors — daily timing is important for consistent blood levels
- Oral targeted therapies (tyrosine kinase inhibitors, CDK4/6 inhibitors etc.) — many have specific dosing requirements
- Anticoagulants (warfarin, novel oral anticoagulants) — timing and monitoring are important; INR testing if on warfarin
- Immunosuppressants — narrow therapeutic windows require careful management
The general approach is to develop a clear schedule for dose timing in both your home time zone and the destination time zone, with a planned transition period. Your pharmacist is the right professional to help develop this, with oncologist input.
Surveillance Tests and Monitoring Overseas
Cancer surveillance — blood tests, tumour markers, imaging, or specialist reviews — continues during and after treatment for good reason. A lengthy worldwide trip may require planning these in your destination country. Consider:
- Blood tests: Most international private hospitals and clinics can run standard haematology and chemistry panels. Your oncologist can provide a testing schedule and interpretation reference ranges.
- Tumour markers (PSA, CA-125, CA19-9, CEA etc.): widely available in most developed countries. Results need interpretation in the context of your prior values — carry your baseline results.
- Imaging (CT, PET, MRI): available in major cities worldwide in private hospitals. Requires planning, advance booking, and usually a local physician referral.
- Oncology consultations: some world-class cancer centres (Mayo Clinic, MD Anderson, Royal Marsden) offer international patient consultations, which could be incorporated into a trip if specialist input is needed.
Carrying enough medication for a 4-week or longer worldwide trip, plus buffer, is a logistical exercise worth doing carefully. Considerations include:
- Check customs and importation rules for your medications in every country on your itinerary — some medications, particularly opioids and certain controlled drugs, have strict importation requirements
- Carry medications in original pharmacy-labelled containers with your prescription documentation
- Split your supply between carry-on and checked luggage as a precaution against baggage loss, but keep the full supply for the first week in carry-on
- Research whether your medication is available in equivalent form in your primary destination as a contingency
What Your Travel Insurance Must Cover
For worldwide long-haul travel:
- Unlimited medical expenses — or the highest available limit; for USA-inclusive itineraries, this is non-negotiable
- Medical evacuation and repatriation home — not just to the nearest hub, but back to your home city
- All countries covered — a worldwide policy must genuinely cover every country on your itinerary
- DVT and PE covered — some policies exclude clotting events; for cancer patients, this exclusion is unacceptable
- Cancer declared and accepted as a covered pre-existing condition
- Trip duration match — ensure your policy covers the full duration of your trip, including any planned extension
Timing Your Trip Around Treatment
Long-haul worldwide trips require the most careful treatment-cycle planning:
- The further you are from home, the longer it takes to get you back in an emergency — factor this into your risk comfort level
- Extended trips may require arranging overseas blood tests or oncology reviews — establish this plan before departure
- Consider the health window in your treatment cycle — the weeks of best immune function and energy are the right time for the most active or remote portions of your itinerary
Tips for Getting the Best Cover
1. Get a worldwide policy, not a collection of regional policies. A single worldwide policy is cleaner, has clear coverage everywhere, and avoids gaps at borders.
2. Declare every country on your itinerary. Some worldwide policies exclude certain high-risk countries (some African nations, conflict zones). Confirm your full route is covered.
3. Address DVT proactively. Have the DVT risk conversation with your oncologist before booking, not after. Get a written recommendation for in-flight prophylaxis to carry with your travel documents.
4. Plan your medication supply and timing in writing. A typed medication schedule that specifies what to take, when, and what the home-vs-destination time zone transition looks like, signed by your pharmacist or oncologist, is invaluable.
5. Research surveillance test availability in advance. If you will need blood tests or imaging during your trip, identify the clinic or private hospital where you can access these in your primary destination country.
6. Buy your insurance before any deposits. A worldwide trip involves significant non-refundable expenditure — flights, tours, accommodation. Your cancellation cover only applies to events that occur after your policy is in place.
Indicative Premium
From ~NZ$400 for a 4-week worldwide policy with cancer cover (varies significantly by age, cancer type, and specific destinations)
Premiums vary significantly by age, cancer history, trip length, and insurer. Compare multiple providers for the most accurate pricing.
Frequently Asked Questions
How much does DVT risk actually increase for cancer patients on long-haul flights?+
What is a "worldwide" travel insurance policy and do I need one for a Europe trip?+
Can I arrange cancer surveillance tests (blood tests, tumour markers) while overseas?+
How do I manage warfarin or other anticoagulants during international long-haul travel?+
Can I buy worldwide travel insurance after I've already left on my trip?+
Get Covered for Worldwide / Long-Haul
Compare all major providers to find the best cancer cover for your trip.
Compare Providers →